It appears no one is close to FC for HBV. JNJ and ARWR seem quite happy with their results yet not close to FV for most. Perhaps the best one can hope for is to improve upon current SoC. Tweaking old molecules would be one approach.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.